These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 11753617)

  • 1. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications.
    Gupta D; Treon SP; Shima Y; Hideshima T; Podar K; Tai YT; Lin B; Lentzsch S; Davies FE; Chauhan D; Schlossman RL; Richardson P; Ralph P; Wu L; Payvandi F; Muller G; Stirling DI; Anderson KC
    Leukemia; 2001 Dec; 15(12):1950-61. PubMed ID: 11753617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The interaction of vascular endothelial growth factor and interleukin-6 in multiple myeloma].
    Zhang L; Chen SL; Chen WM; Liu JW
    Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):85-8. PubMed ID: 15840215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapies targeting the myeloma cell and its bone marrow microenvironment.
    Hideshima T; Chauhan D; Podar K; Schlossman RL; Richardson P; Anderson KC
    Semin Oncol; 2001 Dec; 28(6):607-12. PubMed ID: 11740818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms.
    Nefedova Y; Landowski TH; Dalton WS
    Leukemia; 2003 Jun; 17(6):1175-82. PubMed ID: 12764386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion.
    Uchiyama H; Barut BA; Mohrbacher AF; Chauhan D; Anderson KC
    Blood; 1993 Dec; 82(12):3712-20. PubMed ID: 8260708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of thalidomide on bone marrow microenvironment in refractory and relapsed multiple myeloma].
    Li J; Luo SK; Hong WD; Zhou ZH; Zou WY
    Ai Zheng; 2003 Apr; 22(4):346-9. PubMed ID: 12703985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-lapachone, a novel plant product, overcomes drug resistance in human multiple myeloma cells.
    Gupta D; Podar K; Tai YT; Lin B; Hideshima T; Akiyama M; LeBlanc R; Catley L; Mitsiades N; Mitsiades C; Chauhan D; Munshi NC; Anderson KC
    Exp Hematol; 2002 Jul; 30(7):711-20. PubMed ID: 12135668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma.
    Bisping G; Leo R; Wenning D; Dankbar B; Padró T; Kropff M; Scheffold C; Kröger M; Mesters RM; Berdel WE; Kienast J
    Blood; 2003 Apr; 101(7):2775-83. PubMed ID: 12517814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma.
    Dankbar B; Padró T; Leo R; Feldmann B; Kropff M; Mesters RM; Serve H; Berdel WE; Kienast J
    Blood; 2000 Apr; 95(8):2630-6. PubMed ID: 10753844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel biologically based therapies for myeloma.
    Anderson KC
    Cancer J; 2001; 7 Suppl 1():S19-23. PubMed ID: 11504280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu.
    Hideshima T; Akiyama M; Hayashi T; Richardson P; Schlossman R; Chauhan D; Anderson KC
    Blood; 2003 Jan; 101(2):703-5. PubMed ID: 12393542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B.
    Chauhan D; Uchiyama H; Akbarali Y; Urashima M; Yamamoto K; Libermann TA; Anderson KC
    Blood; 1996 Feb; 87(3):1104-12. PubMed ID: 8562936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment.
    Hayashi T; Hideshima T; Nguyen AN; Munoz O; Podar K; Hamasaki M; Ishitsuka K; Yasui H; Richardson P; Chakravarty S; Murphy A; Chauhan D; Higgins LS; Anderson KC
    Clin Cancer Res; 2004 Nov; 10(22):7540-6. PubMed ID: 15569984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
    Hideshima T; Neri P; Tassone P; Yasui H; Ishitsuka K; Raje N; Chauhan D; Podar K; Mitsiades C; Dang L; Munshi N; Richardson P; Schenkein D; Anderson KC
    Clin Cancer Res; 2006 Oct; 12(19):5887-94. PubMed ID: 17020997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of selective cytokine inhibitory drugs (CC-10004 and CC-1088) on VEGF and IL-6 expression and apoptosis in myeloma and endothelial cell co-cultures.
    Molostvov G; Morris A; Rose P; Basu S; Muller G
    Br J Haematol; 2004 Feb; 124(3):366-75. PubMed ID: 14717786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups.
    Bisping G; Kropff M; Wenning D; Dreyer B; Bessonov S; Hilberg F; Roth GJ; Munzert G; Stefanic M; Stelljes M; Scheffold C; Müller-Tidow C; Liebisch P; Lang N; Tchinda J; Serve HL; Mesters RM; Berdel WE; Kienast J
    Blood; 2006 Mar; 107(5):2079-89. PubMed ID: 16278310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines.
    Kim I; Uchiyama H; Chauhan D; Anderson KC
    Br J Haematol; 1994 Jul; 87(3):483-93. PubMed ID: 7993788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interdependence between cytokines and cell adhesion molecules to induce interleukin-6 production by stromal cells in myeloma.
    Thomas X; Anglaret B; Magaud JP; Epstein J; Archimbaud E
    Leuk Lymphoma; 1998 Dec; 32(1-2):107-19. PubMed ID: 10037006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies.
    Bellamy WT
    Semin Oncol; 2001 Dec; 28(6):551-9. PubMed ID: 11740808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of proangiogenic cytokines during thalidomide treatment of multiple myeloma.
    Dmoszyńska A; Bojarska-Junak A; Domański D; Roliński J; Hus M; Soroka-Wojtaszko M
    Leuk Lymphoma; 2002 Feb; 43(2):401-6. PubMed ID: 11999576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.